Prelude Therapeutics (PRLD) Change in Cash (2019 - 2026)
Prelude Therapeutics (PRLD) reported Change in Cash of -$13.5 million for Q1 2026, down 148.57% on a YoY basis from $27.8 million in Q1 2025, and down 9.97% sequentially from -$12.3 million in Q4 2025.
Prelude Therapeutics (PRLD) Change in Cash (2019 - 2026) Analysis & Trends
Prelude Therapeutics (PRLD) has 8 years of Change in Cash data on file, last reported at -$13.5 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Cash fell 148.57% year-over-year to -$13.5 million; the trailing twelve-month figure through Mar 2026 stood at -$19.3 million (down 224.16% YoY), and the FY2025 full-year result was $22.0 million, up 271.44% from the prior year.
- Change in Cash fell to -$13.5 million in Q1 2026, from -$12.3 million in the prior quarter.
- In the past five years, Change in Cash ranged from a high of $27.8 million in Q1 2025 to a low of -$21.4 million in Q4 2022.
- A 5-year average of -$640058.8 and a median of -$584000.0 in 2024 frame the typical range for Change in Cash.
- Peak annual rise in Change in Cash reached 4859.42% in 2025, while the deepest fall reached 1016.12% in 2025.
- Tracing PRLD's Change in Cash over 5 years: stood at -$21.4 million in 2022, then soared by 143.87% to $9.4 million in 2023, then slumped by 85.74% to $1.3 million in 2024, then plunged by 1016.12% to -$12.3 million in 2025, then slipped by 9.97% to -$13.5 million in 2026.
- Business Quant data shows PRLD's Change in Cash at -$13.5 million in Q1 2026, -$12.3 million in Q4 2025, and $21.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -22.03 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 243.78 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.34 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 417.10 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -153.10 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 57.19 Mn |
| 10 | Prelude Therapeutics | 324.30 Mn | 179.71 Mn | - | -13.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13.50 Mn |
| Dec 31, 2025 | -12.28 Mn |
| Sep 30, 2025 | 20.97 Mn |
| Jun 30, 2025 | -14.52 Mn |
| Mar 31, 2025 | 27.80 Mn |
| Dec 31, 2024 | 1.34 Mn |
| Sep 30, 2024 | -16.69 Mn |
| Jun 30, 2024 | 3.12 Mn |
| Mar 31, 2024 | -584,000.00 |
| Dec 31, 2023 | 9.40 Mn |
| Sep 30, 2023 | -10.55 Mn |
| Jun 30, 2023 | 8.25 Mn |
| Mar 31, 2023 | -12.40 Mn |
| Dec 31, 2022 | -21.42 Mn |
| Sep 30, 2022 | 1.32 Mn |
| Jun 30, 2022 | -928,000.00 |
| Mar 31, 2022 | 19.81 Mn |
| Dec 31, 2021 | -25.55 Mn |
| Sep 30, 2021 | -281.70 Mn |
| Jun 30, 2021 | -19.87 Mn |